title: Mechanisms of oxidized chylomicron-induced leukocyte-endothelial cell adhesion.
abstract: The objectives of this study were to determine whether oxidatively modified chylomicrons (oxCM) can elicit leukocyte-endothelial cell adhesion in the mesenteric microcirculation and to define the mechanisms underlying the oxCM-induced adhesive interactions. Oxidation of chylomicrons (CM) with the peroxyl radical generator 2,2'-azobis(2-amidinopropane)hydrochloride was associated with the formation of thiobarbituric acid-reactive substances and lipid hydroperoxides. Leukocyte rolling, adherence, and emigration as well as erythrocyte velocity were monitored in rat mesenteric venules infused with either native CM or oxCM. oxCM, but not native CM, increased the numbers of rolling, adherent, and emigrated leukocytes. The oxCM-induced leukocyte adherence was significantly blunted by pretreating the animals with either superoxide dismutase, a platelet-activating factor (PAF) receptor antagonist, or monoclonal antibodies (MAb) directed against either CD11/CD18 or intracellular adhesion molecule 1. A MAb against P-selectin reduced oxCM-induced leukocyte rolling but not adherence. These findings suggest that the increased plasma oxCM levels associated with ingestion of oxidized lipids may promote leukocyte adhesion through a mechanism that involves the superoxide anion, PAF, and adhesion receptors on leukocytes and endothelial cells.
authors.affiliation: Department of Physiology, Louisiana State University Medical Center, Shreveport 71130, USA.
authors.forename: H
authors.initials: H
authors.lastname: Kurtel
authors.forename: L
authors.initials: L
authors.lastname: Liao
authors.forename: M B
authors.initials: MB
authors.lastname: Grisham
authors.forename: P
authors.initials: P
authors.lastname: Tso
authors.forename: T Y
authors.initials: TY
authors.lastname: Aw
authors.forename: D C
authors.initials: DC
authors.lastname: Anderson
authors.forename: M
authors.initials: M
authors.lastname: Miyasaka
authors.forename: D N
authors.initials: DN
authors.lastname: Granger
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D001381:Azepines / Q000494:pharmacology; D018821:CD18 Antigens / Q000276:immunology / Q000502:physiology; D002448:Cell Adhesion / Q000187:drug effects*; D015815:Cell Adhesion Molecules / Q000494:pharmacology; D002914:Chylomicrons / Q000494:pharmacology*; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000494:pharmacology; D007962:Leukocytes / Q000187:drug effects / Q000502:physiology*; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D008833:Microcirculation; D010084:Oxidation-Reduction; D019007:P-Selectin; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors; D010980:Platelet Membrane Glycoproteins / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013152:Splanchnic Circulation; D013482:Superoxide Dismutase / Q000494:pharmacology; D017392:Thiobarbituric Acid Reactive Substances / Q000032:analysis; D014230:Triazoles / Q000494:pharmacology
chemical_list: D000911:Antibodies, Monoclonal; D001381:Azepines; D018821:CD18 Antigens; D015815:Cell Adhesion Molecules; D002914:Chylomicrons; D019007:P-Selectin; D010972:Platelet Activating Factor; D010980:Platelet Membrane Glycoproteins; D017392:Thiobarbituric Acid Reactive Substances; D014230:Triazoles; C052518:WEB 2086; D018799:Intercellular Adhesion Molecule-1; D013482:Superoxide Dismutase